A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis

N Engl J Med. 2024 May 2;390(17):1632. doi: 10.1056/NEJMc2402905.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Clinical Trials, Phase III as Topic
  • Humans
  • Iodide Peroxidase
  • Liver Cirrhosis* / etiology
  • Liver Cirrhosis* / therapy
  • Male
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease* / complications
  • Non-alcoholic Fatty Liver Disease* / drug therapy
  • Non-alcoholic Fatty Liver Disease* / pathology
  • Pyridazines*
  • Thyroxine / blood

Substances

  • resmetirom
  • Thyroxine
  • Iodide Peroxidase
  • Pyridazines